Driving evolution in health
AI-driven transformation
With 130 clubs and 750,000 members, David Lloyd Health Clubs wanted to evolve.
Together with PwC UK, they launched an ambitious AI-driven transformation to enhance member experiences, deliver operational efficiencies and become a holistic health and well-being brand.
From integrating cloud-based SaaS solutions, improving business intelligence and simplifying processes, to deploying AI chatbots to enhance member interactions. PwC’s AI consultants helped them create success today and lay the foundations for tomorrow.
Mitigating flood disasters
AI flood resilience tool
Floods have displaced 24 million people and caused US$453 billion in damages in the past decade.
PwC Middle East’s AI-driven flood resilience tool uses geospatial AI to create dynamic, real-time simulations of potential flooding scenarios, incorporating data on topography, rainfall, cyclones and proximity to the ocean.
The 3D visualisations make it easy to understand the likely flow of the flood—helping government agencies, emergency services, insurance companies and homeowners mitigate loss and harm for the future.
Optimising refugee resources
AI model to guide interventions
The unpredictability and urgency of refugee movements make it difficult for public authorities to cope, balancing costs and local community impact.
PwC Netherlands developed a powerful AI model that uses data, community research and expert knowledge to provide authorities with quantitative insights into potential interventions—from education to employment, sports to transport.
Originally designed to support Ukrainian refugees, it outperforms human strategies. And the model can be easily adapted by decision-makers and NGOs anywhere—to improve trust and support with data-driven approaches.
Developing faster, smarter clinical trials
Accelerating vital treatments with AI
Clinical trials can take up to 10–15 years and cost billions of dollars, greatly hampering the delivery of new treatments.
PwC US has been working with a leading pharma company to improve the process. With alliance partners AWS and Microsoft, PwC US used data analytics and GenAI to design a new clinical trial and integrated tech platform.
The results were significant: costs were reduced, the findings were more precise, time was cut by 20–25% and revenue increased by more than US$100 million. This approach could revolutionise a wide range of drug trials, benefiting patients and accelerating treatments.